بدائل البحث:
decrease therapeutic » increased therapeutic (توسيع البحث), degrader therapeutics (توسيع البحث), great therapeutic (توسيع البحث)
new therapeutic » novel therapeutic (توسيع البحث), _ therapeutic (توسيع البحث)
i resistance » _ resistance (توسيع البحث), high resistance (توسيع البحث), acid resistance (توسيع البحث)
decrease i » decrease _ (توسيع البحث), decreases _ (توسيع البحث), decreased _ (توسيع البحث)
يعرض 161 - 180 نتائج من 16,490 نتيجة بحث عن '(( ((decrease therapeutic) OR (new therapeutic)) research ) OR ( decrease i resistance ))', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 161
    Supplementary Figure 2 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts

    Supplementary Figure 2 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts حسب Verena Paulitschke (134709)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  2. 162
    Supplementary Figure 3 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts

    Supplementary Figure 3 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts حسب Verena Paulitschke (134709)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  3. 163
    Supplementary Figure 1 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts

    Supplementary Figure 1 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts حسب Verena Paulitschke (134709)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  4. 164
    Supplementary Figure 4 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts

    Supplementary Figure 4 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts حسب Verena Paulitschke (134709)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  5. 165
    Figure S6 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S6 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes حسب Pauline J. van der Watt (15068109)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  6. 166
    Figure S2 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S2 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes حسب Pauline J. van der Watt (15068109)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  7. 167
    Figure S7 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S7 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes حسب Pauline J. van der Watt (15068109)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  8. 168
    Figure S5 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S5 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes حسب Pauline J. van der Watt (15068109)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  9. 169
    Figure S4 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S4 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes حسب Pauline J. van der Watt (15068109)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  10. 170
    Figure S1 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S1 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes حسب Pauline J. van der Watt (15068109)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  11. 171
    Figure S3 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S3 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes حسب Pauline J. van der Watt (15068109)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  12. 172
    Supplementary Table and Supplementary Figures 1 through 6 from Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

    Supplementary Table and Supplementary Figures 1 through 6 from Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer حسب Kristin J. Lastwika (3345554)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  13. 173
    IKK KO in microglia leads to increased accumulation of PK-resistant PrP <i>in vitro</i> but decreased accumulation <i>in vivo.</i>

    IKK KO in microglia leads to increased accumulation of PK-resistant PrP <i>in vitro</i> but decreased accumulation <i>in vivo.</i> حسب Arielle J. D. Hay (15456341)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  14. 174
    Figure S4 from Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer

    Figure S4 from Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer حسب Elia Farah (14933502)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  15. 175
    Supplementary Table 1-2, Figures S1-4 from siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer

    Supplementary Table 1-2, Figures S1-4 from siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutam... حسب Yoshiaki Yamamoto (2920581)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  16. 176
    Supplementary Figure S6 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

    Supplementary Figure S6 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma حسب Ilaria Buondonno (2211751)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  17. 177
    Supplementary Figure S7 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

    Supplementary Figure S7 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma حسب Ilaria Buondonno (2211751)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  18. 178
    Supplementary Figure S3 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

    Supplementary Figure S3 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma حسب Ilaria Buondonno (2211751)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  19. 179
    Supplementary Figure S2 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

    Supplementary Figure S2 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma حسب Ilaria Buondonno (2211751)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:
  20. 180
    Supplementary Figure S5 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

    Supplementary Figure S5 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma حسب Ilaria Buondonno (2211751)

    منشور في 2023
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: